OMZYA Trademark

Trademark Overview

On Wednesday, July 31, 2019, a trademark application was filed for OMZYA with the United States Patent and Trademark Office. The USPTO has given the OMZYA trademark a serial number of 88553116. The federal status of this trademark filing is REGISTERED as of Tuesday, May 25, 2021. This trademark is owned by Neurana Pharmaceuticals, Inc.. The OMZYA trademark is filed in the Pharmaceutical Products category with the following description:

Non-opioid treatment for acute and painful muscle spasms
omzya

General Information

Serial Number88553116
Word MarkOMZYA
Filing DateWednesday, July 31, 2019
Status700 - REGISTERED
Status DateTuesday, May 25, 2021
Registration Number6365091
Registration DateTuesday, May 25, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesNon-opioid treatment for acute and painful muscle spasms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 14, 2019
Primary Code005
First Use Anywhere DateWednesday, March 17, 2021
First Use In Commerce DateWednesday, March 17, 2021

Trademark Owner History

Party NameNeurana Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
Party NameNeurana Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
Party NameNeurana Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events

Event DateEvent Description
Tuesday, May 25, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, April 22, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 21, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 13, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 30, 2021USE AMENDMENT FILED
Tuesday, April 13, 2021EXTENSION 2 GRANTED
Tuesday, March 30, 2021EXTENSION 2 FILED
Monday, April 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 30, 2021TEAS EXTENSION RECEIVED
Tuesday, March 30, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020EXTENSION 1 GRANTED
Monday, December 14, 2020EXTENSION 1 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 11, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, December 6, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 28, 2019ASSIGNED TO EXAMINER
Wednesday, August 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 3, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

omzya muscle spasms painful acute treatment opioid